Pedro Huertas's most recent trade in Inozyme Pharma Inc was a trade of 36,074 Stock Option (Right to buy) done . Disclosure was reported to the exchange on Jan. 13, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inozyme Pharma Inc | Pedro Huertas | SVP, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2021 | 36,074 | 36,074 | - | - | Stock Option (Right to buy) |